by admin | Apr 19, 2024 | Article
Dr. Joyce Rauch, Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec Principal: Dr. Joyce Rauch Team members: Céleste Pilon, Elena Lonina, Dr. Jerrold S. Levine, Dr. Maziar Divangahi, Dr. Ciriaco Piccirillo, Dr. Jose A....
by admin | Apr 19, 2024 | Article
Vaccination records or receipts are issued by your province or territory. Current COVID-19 vaccination documents aren’t standardized for international travel. Some provinces and territories have created a secure proof of vaccination document for non-essential services...
by admin | Apr 19, 2024 | Article
Dr. Murray Urowitz, University Health Network, Toronto, Ontario Principal: Dr. Murray Urowitz Team members: Dr. Dafna Gladman, Dr. Zahi Touma, Dr. Konstantinos Tselios, Dr. Jiandong Su A major goal of clinical research in lupus is to improve disease management based...
by admin | Apr 19, 2024 | Article
Please visit https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/statement-september-10-2021-additional-dose-covid-19-vaccine-immunocompromised-following-1-2-dose-series.html for details.
by admin | Apr 19, 2024 | Article
If you’re moderately to severely immunocompromised due to disease or treatment, you may have a lower immune response to COVID-19 vaccination. NACI recommends you get an additional mRNA vaccine dose following your 1- or 2-dose vaccine series. The additional dose should...
by admin | Apr 19, 2024 | Article
Dr. Christine A. Peschken, University of Manitoba, Winnipeg, Manitoba Chair, Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS) This research network includes over 30 researchers and personnel involved in the research or its activities at...
